Lawrence Steinman, Director at 180 Life Sciences Corp. (ATNF), bought 5,000 shares at $4.27 ($21K) on 2021-12-09, disclosed to the SEC on 2021-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KTTA | BUY | 2023-06-06 | $13K | — | Filing → |
| ATNF | BUY | 2023-06-02 | $22K | — | Filing → |
| BCAB | SELL | 2021-11-03 | $14K | — | Filing → |